Small Molecule Innovator CDMO Market Size, Share & Review 2024-2030

Small Molecule Innovator CDMO Industry Overview

The global small molecule innovator CDMO market size was estimated at USD 48.6 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 6.21% from 2024 to 2030. Key drivers for this growth are increasing pharmaceutical R&D investment, growing demand for small molecules, and rising incidence of cancer & age-related disorders. Biological drugs are more expensive than small molecules. Hence, growing demand for cost-effective drugs is expected to further support market growth.

The COVID-19 pandemic significantly impacted on global economy in 2020 and caused an ongoing impact on various industries. However, the market for contract development and manufacturing organization (CDMO) witnessed a positive impact due to this pandemic. CDMOs played an important role in meeting the needs of pharmaceutical companies, biotech companies, and other end-users during this crisis. Overall, pandemic boosted market demand for small molecule innovator drugs. With the growing demand for outsourcing by pharma companies, heightened demand is observed in post-pandemic scenario.

Gather more insights about the market drivers, restrains and growth of theSmall Molecule Innovator CDMO Market

Small Molecule Innovator CDMO Market Segmentation

Grand View Research has segmented the global small molecule innovator CDMO market basedon product, stage type, customer type, therapeutic area, and region:

Small Molecule Innovator CDMOProduct Outlook (Revenue, USD Million, 2018 - 2030)

• Small Molecule API
• Small Molecule Drug Product

oOral solid dose

oSemi-Solid Dose

oLiquid Dose

oOthers

Small Molecule Innovator CDMOStage Type Outlook (Revenue, USD Million, 2018 - 2030)

• Preclinical
• Clinical

oPhase I

• Small
• Medium
• Large

oPhase II

• Small
• Medium
• Large

oPhase III

• Small
• Medium
• Large
• Commercial

Small Molecule Innovator CDMOCustomer Type Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical

oSmall

oMedium

oLarge

oBiotechnology

Small Molecule Innovator CDMOTherapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)

• Cardiovascular disease
• Oncology
• Respiratory disorders
• Neurology
• Metabolic disorders
• Infectious disease
• Others

Small Molecule Innovator CDMORegional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o US

oCanada

• Europe

oUK

oGermany

oFrance

oItaly

oSpain

oDenmark

oSweden

oNorway

• Asia Pacific

oIndia

oJapan

oChina

oAustralia

oSouth Korea

oThailand

• Latin America

oBrazil

oMexico

oArgentina

• Middle East & Africa

oSouth Africa

oSaudi Arabia

oUAE

oKuwait

Browse through Grand View Research'sMedical Devices IndustryResearch Reports.

• The globalintrauterine devices marketsize was estimated at USD 6.25 billion in 2023 and is projected to grow at a CAGR of 3.66% from 2024 to 2030.
• The globaldual chamber prefilled syringes marketsize was valued at USD 167.3 million in 2023 and is projected to grow at a CAGR of 5.8% from 2024 to 2030.

Key Companies & Market Share Insights

Companies are undertaking various strategic initiatives to gain a competitive advantage. Key parameters affecting the competitive nature of the market include acquisition, geographic expansion, mergers, acquisitions, and product launches.

In September 2022, WuXi STA inaugurated a new sterile lipid nanoparticle (LNP) formulation development and manufacturing facility at its Wuxi city campus. The integrated drug product platform CRDMO provides a full range of services, including solid-state development, pre-formulation, and clinical to commercial drug product manufacturing.

In June 2022, Lonza inaugurated a new clinical phase development and manufacturing facility in its small molecules site in Bend, Oregon. It is dedicated to manufacturing bioavailability-enhancing spray-dried dispersion (SDD) finished dosage forms and drug product intermediates

List of Key Players of Small Molecule Innovator CDMO Market

• Piramal Pharma Solutions
• CordenPharma International
• Wuxi AppTec
• Cambrex Corporation
• Recipharm AB
• Pantheon (Thermo Fisher Scientific)
• Lonza
• Catalent Inc.
• Siegfried Holding AG
• Boehringer Ingelheim
• Labcorp Drug Development

Order a free sample PDFof the Small Molecule Innovator CDMO Market Intelligence Study, published byGrand View Research.